跳至主要内容
临床试验/ISRCTN35143689
ISRCTN35143689已完成不适用

Candesartan in renal artery stenosis (CARLAS)

AstraZeneca (Sweden)0 个研究点目标入组 200 人开始时间: 2007年12月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Blood pressure above 140 mmHg/90 mmHg
  • 2. Confirmation of renal artery stenosis by either duplex ultrasonography, CT-angiography or MR-angiography

排除标准

  • 1. Renal size <7.5 cm at the stenotic side
  • 2. Age >80 years
  • 3. Pregnancy or nursing mother
  • 4. Terminal renal failure (Glomerular Filtration Rate [GFR] <15 ml/min)
  • 5. Treatment with Angiotensin-Converting Enzyme (ACE) inhibitors or angiotensin receptor blockers
  • 6. Renovascular hypertension of other etiology than atherosclerosis or Flow-Mediated Dilation (FMD)
  • 7. Chronic glomerular disease with urinary albumin excretion (in mg/24h) (tU-alb) >1g/day
  • 8. Diabetic nephropathy with tU-alb >0.3 g/day
  • 9. Contraindication for renal angiography/PTRA (eg. serious contrast allergy)
  • 10. Other forms of secondary hypertension
  • 11. Serious malignant disease
  • 12. Treatment with immune-modulating medications eg. cyclosporin and oral steroids

研究者

发起方
AstraZeneca (Sweden)

相似试验